Filed (PHiled). Greater than 1-2 years since publication

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

Marius M. Hoeper, David B. Badesch, H. Ardeschir Ghofrani, J. Simon R. Gibbs, Mardi Gomberg-Maitland, Valerie V. McLaughlin, Ioana R. Preston, Rogerio Souza, Aaron B. Waxman, Ekkehard Grünig, Grzegorz Kopeć, Gisela Meyer, Karen M. Olsson, Stephan Rosenkranz, Yayun Xu, Barry Miller, Marcie Fowler, John Butler, Jeorg Koglin, Janethe de Oliveira Pena, and Marc Humbert, for […]

Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension Read More »

Echocardiographic Predictors of Hospital Outcomes in Preterm Neonates with Patent Ductus Arteriosus and Clinical Suspicion of Pulmonary Hypertension

Kristen Graff, Julie R. Ross, Kristen Morella, Shahryar M. ChowdhuryMedical University of South Carolina.United States Journal of NeonatologyJ Neonatol 2023; 37: 384-389DOI: 10.1177/09732179231178127 AbstractBackground: Preterm neonates often have an echocardiogram performed in the first few days of life for suspicion of pulmonary hypertension and patent ductus arteriosus. The usefulness of this echocardiogram in predicting outcomes in this

Echocardiographic Predictors of Hospital Outcomes in Preterm Neonates with Patent Ductus Arteriosus and Clinical Suspicion of Pulmonary Hypertension Read More »

Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors

Herlina Dimiati Dimas Arya Umara, Iflan NaufalUniversitas Syiah Kuala,Indonesia F1000 ResearchF1000Res 2022; DOI: 10.12688/f1000research.53966.2 AbstractRespiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first occurred in Wuhan, China, in December 2019 and was declared as a pandemic by WHO. The interaction between the 2019 coronavirus disease (COVID-19) and pulmonary hypertension (PH) in children

Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors Read More »

Feasibility, Safety, and Efficacy of the Atrial Flow Regulator in Pediatric Patients: A Single-Center Experience

Biagio Castaldi, Elena Cuppini, Domenico Sirico, Irene Cattapan, Jennifer Fumanelli, Alice Pozza, Giovanni Di SalvoUniversity Hospital of Padova.Italy Journal of the Society for Cardiovascular Angiography and InterventionsJ Soc Cardiovasc Angiogr Interv 2023; 2(6Part B):DOI: 10.1016/j.jscai.2023.101209 AbstractBackground: The Atrial Flow Regulator (AFR; Occlutech) can be used to create interatrial communication with a predetermined diameter in various pathophysiological settings.

Feasibility, Safety, and Efficacy of the Atrial Flow Regulator in Pediatric Patients: A Single-Center Experience Read More »

Trametinib for Refractory Chylous Effusions and Systemic Complications in Children with Noonan Syndrome

Taizo A. Nakano, Alexander W. Rankin, Aparna Annam, Ann M. Kulungowski, Leslie M. McCallen, Lauren R. Hill, Kathryn C. ChatfieldUniversity of Colorado Anschutz Medical Campus and Children’s Hospital Colorado. United States Journal of PediatricsJ Pediatr 2022; 248: 81-88DOI: 10.1016/j.jpeds.2022.05.030 AbstractObjective: To evaluate the effect of the RAS-MAPK pathway inhibitor trametinib on medically refractory chylous effusions in 3

Trametinib for Refractory Chylous Effusions and Systemic Complications in Children with Noonan Syndrome Read More »

Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertension

Sebastian G. Michel, Maja Hanuna, Joseph Pattathu, Jelena Pabst von Ohain, Christian Schneider, Theresa Kauke, Nikolaus Kneidinger, Juergen Behr, Katrin Milger, Juergen Barton, Tobias Veit, Christine Kamla, Christoph Mueller, Robert Dzieciol, Lauren Christen, Michael Irlbeck, Roland Tomasi, Jan Abicht, Patrick Scheiermann, Matthias Feuerecker, Robert Dalla-Pozza, Marcus Fischer, Andre Jakob, Matthias Hermann, Nikolaus Haas, Christian Hagl,

Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertension Read More »

Direct Percutaneous Transthoracic Cardiac Access for Recanalization of Longstanding Branch Pulmonary Artery Atresia

Christopher J. Petit, R. Allen LigonChildren’s Healthcare of Atlanta and Emory University School of Medicine.United States Journal of the American College of Cardiology Case ReportsJACC Case Reports 2020; 3: 180-186DOI: 10.1016/j.jaccas.2020.09.025 AbstractWe describe the use of direct percutaneous cardiac access to recanalize an atretic right pulmonary artery in an adolescent with complex congenital heart disease and

Direct Percutaneous Transthoracic Cardiac Access for Recanalization of Longstanding Branch Pulmonary Artery Atresia Read More »

Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights

Michael J. Landzberg, Curt J. Daniels, Paul Forfia, Vallerie V. McLaughlin, Karimah S. Bell Lynum, Mona Selej, Alexander R. OpotowskyHarvard Medical School, Brigham and Women’s Hospital and Boston Children’s Hospital. Ohio State University College of Medicine and Nationwide Children’s Hospital. Temple University Hospital. University of Michigan Medical Center. Actelion Pharmaceuticals US, Inc. Cincinnati Children’s Hospital

Timely PAH Identification in Adults With Repaired Congenital Heart Disease? The ACHD-QuERI Registry Insights Read More »

Pulmonary artery and lung parenchymal growth following early versus delayed stent interventions in a swine pulmonary artery stenosis model

Ryan Pewowaruk, Joshua Hermsen, Cody Johnson, Alexandra Erdmann, Kevin Pettit, Scott Aesif, J. Carter Ralphe, Christopher J. Francois, Alejandro Roldán Alzate, Luke LamersUniversity of Wisconsin-Madison. United States Catheterization and Cardiovascular InterventionsCateter Carderiovas Interv 2020; 96: 1454-1464DOI: 10.1002/ccd.29326 AbstractObjectives: Compare lung parenchymal and pulmonary artery (PA) growth and hemodynamics following early and delayed PA stent interventions for treatment

Pulmonary artery and lung parenchymal growth following early versus delayed stent interventions in a swine pulmonary artery stenosis model Read More »

Prenatal features of ductus arteriosus-related branch pulmonary stenosis in fetal pulmonary atresia

Deliwe P. Ngwezi, Marisha McClean, Angela McBrien, Luke Eckersley, Jayani Abeysekera, Timothy Colen, Lisa K. HornbergerStollery Children’s Hospital and University of Alberta.Canada Ultrasound in Obstetrics and GynecologyUltrasound Obstet Gynecol 2021; 58: 411-419DOI: 10.1002/uog.23576 AbstractObjective: Ductus arteriosus (DA)-related branch pulmonary stenosis (PS), due to ductal tissue migration into the proximal pulmonary artery (PA) ipsilateral to the DA, is

Prenatal features of ductus arteriosus-related branch pulmonary stenosis in fetal pulmonary atresia Read More »

Scroll to Top